Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts | Advertise | Reader Login
 
Search Article 
  
Advanced search 
  Users Online: 132 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  
Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
  Citation statistics : Table of Contents
   2013| November  | Volume 17 | Issue 8  
    Online since November 27, 2013

 
 
  Archives   Previous Issue   Next Issue   Most popular articles   Most cited articles
 
Show all abstracts  Show selected abstracts  Export selected to
  Cited Viewed PDF
ORIGINAL ARTICLES
Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the South India cohort of the A 1 chieve study
S Nallaperumal, Johny Kannampilly
November 2013, 17(8):496-500
DOI:10.4103/2230-8210.122095  PMID:24404490
  6 393 129
Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the Mumbai cohort of the A 1 chieve study
PG Talwalkar, Vishal Gupta, Rajiv Kovil
November 2013, 17(8):516-520
DOI:10.4103/2230-8210.122107  PMID:24404494
  1 466 127
EDITORIALS
The A 1 chieve study: Mapping the Ibn Battuta trail
Sanjay Kalra, Mahdi Kamoun, Siddharth N Shah
November 2013, 17(8):395-396
DOI:10.4103/2230-8210.122038  PMID:24404465
  - 644 177
Kleiber's law and the A 1 chieve study
Sanjay Kalra, Siddharth N Shah, Rakesh Sahay
November 2013, 17(8):397-398
DOI:10.4103/2230-8210.122039  PMID:24404466
  - 742 146
ORIGINAL ARTICLES
Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the Agadir cohort of the A 1 chieve study
Hicham Boussouf, Mahassine Mouniri, Maha Oudrhiri
November 2013, 17(8):399-403
DOI:10.4103/2230-8210.122040  PMID:24404467
  - 476 140
Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the Marrakech cohort of the A 1 chieve study
El Ansari Nawal
November 2013, 17(8):404-407
DOI:10.4103/2230-8210.122041  PMID:24404468
  - 520 128
Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the Casablanca cohort of the A 1 chieve study
Ahmed Farouqi, Asmae Chadli
November 2013, 17(8):408-412
DOI:10.4103/2230-8210.122042  PMID:24404469
  - 436 136
Clinical experience with insulin detemir type 2 diabetes mellitus, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the Rabat-Sale-Zemmour-Zaer Region cohort of the A 1 chieve study
Abdelmjid Chraibi, Ghizlane Belmejdoub
November 2013, 17(8):413-417
DOI:10.4103/2230-8210.122045  PMID:24404470
  - 444 128
Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from North and the oriental region of Morocco cohort of the A 1 chieve study
Othmane Laaribi
November 2013, 17(8):418-421
DOI:10.4103/2230-8210.122047  PMID:24404471
  - 397 116
Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the Saiss cohort of the A 1 chieve study
Farida Ajdi
November 2013, 17(8):422-425
DOI:10.4103/2230-8210.122051  PMID:24404472
  - 395 113
Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the Northern Tunisia cohort of the A 1 chieve study
Samira Blouza, Henda Jamoussi
November 2013, 17(8):426-430
DOI:10.4103/2230-8210.122057  PMID:24404473
  - 419 132
Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the Central and Southern Tunisia cohort of the A 1 chieve study
Mohamed Abid, Ines Khochtali
November 2013, 17(8):431-434
DOI:10.4103/2230-8210.122059  PMID:24404474
  - 478 142
Clinical experience with biphasic insulin aspart in people with type 2 diabetes: Results from the Libya cohort of the A 1 chieve study
Issam M Hajjaji, Ibrahim Sherif, Aisha Elazrag, Suhair Jaber, Praful N Chakkarwar, Salem Eltabal
November 2013, 17(8):435-436
DOI:10.4103/2230-8210.122062  PMID:24404475
  - 485 121
Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the Taif, Saudi Arabia cohort of the A 1 chieve study
Helmy El Gendy, Saud Al Sifri, Mohamed Ghazy
November 2013, 17(8):437-440
DOI:10.4103/2230-8210.122063  PMID:24404476
  - 450 129
Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the Yanbu cohort of the A 1 chieve study
Moody El Harby, Ahmed Saeed
November 2013, 17(8):441-444
DOI:10.4103/2230-8210.122065  PMID:24404477
  - 434 111
Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the Central Saudi Arabia cohort of the A 1 chieve study
Muhamed Shahed Omar, Najim Abdulwahid, Syed Salman Ali
November 2013, 17(8):445-448
DOI:10.4103/2230-8210.122067  PMID:24404478
  - 523 121
Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the Southwest Saudi Arabia cohort of the A 1 chieve study
Waffaa Shawkat, Magdy Abdou, Nadia Ghannam, Ashraf Shaaban Mahfouz
November 2013, 17(8):449-452
DOI:10.4103/2230-8210.122070  PMID:24404479
  - 470 123
Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the Eastern Saudi Arabia cohort of the A 1 chieve study
Faisal Hashim, Muneeb Ahmed Yasser, Oussama Khatib
November 2013, 17(8):453-457
DOI:10.4103/2230-8210.122074  PMID:24404480
  - 428 134
Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the Yemen cohort of the A 1 chieve study
Zayed Atef, Abdulkareem Al-Khawlany, Abdalla A Gunaid
November 2013, 17(8):458-460
DOI:10.4103/2230-8210.122076  PMID:24404481
  - 406 117
Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the Bahraini cohort of the A 1 chieve study
Wiam Ibrahim Hussein, Noha Taha
November 2013, 17(8):461-464
DOI:10.4103/2230-8210.122078  PMID:24404482
  - 442 161
Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the Kuwait cohort of the A 1 chieve study
Alaa Daban, Hussain Haji Ali
November 2013, 17(8):465-468
DOI:10.4103/2230-8210.122080  PMID:24404483
  - 400 119
Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the Qatar cohort of the A 1 chieve study
Mohamed Hasan Daghash, Jabbar Mubarak Raja, Mohamed Milad
November 2013, 17(8):469-471
DOI:10.4103/2230-8210.122081  PMID:24404484
  - 400 115
Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the Dubai cohort of the A 1 chieve study
Zain Gulzar, Laxami Sharma, Thomas Zachariya
November 2013, 17(8):472-476
DOI:10.4103/2230-8210.122084  PMID:24404485
  - 381 129
Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the Abu Dhabi cohort of the A 1 chieve study
Oula Alhabian, Mowafaq Yehyia
November 2013, 17(8):477-481
DOI:10.4103/2230-8210.122085  PMID:24404486
  - 384 127
Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the Oman cohort of the A 1 chieve study
Mustafa Al Abousi
November 2013, 17(8):482-485
DOI:10.4103/2230-8210.122090  PMID:24404487
  - 441 120
Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the West India cohort of the A 1 chieve study
Sunil M Jain, Sushil Jindal, Harshad Malve, Raman Shetty, Anil Bhoraskar
November 2013, 17(8):486-490
DOI:10.4103/2230-8210.122091  PMID:24404488
  - 482 142
Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the North India cohort of the A 1 chieve study
Surender Kumar, AH Zargar, Sagar Singhal, Raman Shetty, MA Ganie, Sarita Bajaj
November 2013, 17(8):491-495
DOI:10.4103/2230-8210.122093  PMID:24404489
  - 466 128
Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the Gujarat cohort of the A 1 chieve study
Banshi Saboo, Mayur Patel
November 2013, 17(8):521-525
DOI:10.4103/2230-8210.122113  PMID:24404495
  - 401 107
Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the Rajasthan cohort of the A 1 chieve study
Akhil Joshi, Anand Meenawat, Rajeev Patni, DC Sharma, Shashi Panicker
November 2013, 17(8):526-529
DOI:10.4103/2230-8210.122116  PMID:24404496
  - 505 126
Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the Delhi cohort of the A 1 chieve study
Sudhir Tripathi, Neeru Gera, Anil Motta, Rajiva Gupta
November 2013, 17(8):530-533
DOI:10.4103/2230-8210.122118  PMID:24404497
  - 440 121
Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the Punjab cohort of the A 1 chieve study
Parminder Singh, KP Singh, Gagan Priya, Rohit Kapoor
November 2013, 17(8):534-537
DOI:10.4103/2230-8210.122120  PMID:24404498
  - 436 112
Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the Haryana cohort of the A 1 chieve study
Sanjay Kalra, Lokesh Garg, Sandeep Suri, Sameer Aggarwal
November 2013, 17(8):538-541
DOI:10.4103/2230-8210.122122  PMID:24404499
  - 415 120
Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the Andhra Pradesh cohort of the A 1 chieve study
Mohammed Abubaker, Y Sadasiva Rao, Samir Hamid Zargar, Raman Shetty, Ravi Shankar
November 2013, 17(8):542-546
DOI:10.4103/2230-8210.122129  PMID:24404500
  - 427 126
Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the Hyderabad cohort of the A 1 chieve study
R Santosh, Ravi Mehrotra, NG Sastry
November 2013, 17(8):547-551
PMID:24404501
  - 496 113
Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the Karnataka cohort of the A 1 chieve study
Neeta Deshpande, Vageesh Ayyar, Rajkumar Channabasavaiah, Raman Shetty, Anish Behl
November 2013, 17(8):552-556
DOI:10.4103/2230-8210.122132  PMID:24404502
  - 422 123
Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the Bangalore cohort of the A 1 chieve study
L Srinivasa Murthy, S Paramesh
November 2013, 17(8):557-560
DOI:10.4103/2230-8210.122135  PMID:24404503
  - 364 105
Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the Kerala cohort of the A 1 chieve study
Sreejith N Kumar, Tom Babu, VM Haridas
November 2013, 17(8):561-564
DOI:10.4103/2230-8210.122136  PMID:24404504
  - 424 116
Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the Trivandrum cohort of the A 1 chieve study
Jothydev Kesavadev
November 2013, 17(8):565-568
DOI:10.4103/2230-8210.122138  PMID:24404505
  - 513 121
Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the Tamil Nadu cohort of the A 1 chieve study
M Shunmugavelu, J Giri, Shahid Akhtar, Raman Shetty, AJ Asirvatham
November 2013, 17(8):569-573
DOI:10.4103/2230-8210.122139  PMID:24404506
  - 437 125
Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the Chennai cohort of the A 1 chieve study
JS Kumar, A Paneerselvam
November 2013, 17(8):574-578
DOI:10.4103/2230-8210.122141  PMID:24404507
  - 371 115
Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the West Bengal cohort of the A 1 chieve study
Satinath Mukhopadhyay, Nilanjan Sengupta, Sujoy Ghosh
November 2013, 17(8):579-583
DOI:10.4103/2230-8210.122142  PMID:24404508
  - 380 133
Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the Kolkata cohort of the A 1 chieve study
Anirban Majumder, Awadhesh Kumar Singh, Kalyan Kumar Gangopadhyay, Ranjini Sen, Raman Shetty, Sujoy Majumdar
November 2013, 17(8):584-587
DOI:10.4103/2230-8210.122144  PMID:24404509
  - 474 144
Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the East India cohort of the A 1 chieve study
Abhay Kumar Sahoo, Sambit Das, Pitambar Prusty, Anand Shankar, Shaibal Guha
November 2013, 17(8):501-505
DOI:10.4103/2230-8210.122096  PMID:24404491
  - 497 110
Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the North East India cohort of the A 1 chieve study
Debmalya Sanyal, Debasis Basu, Mihir Saikia
November 2013, 17(8):506-510
DOI:10.4103/2230-8210.122102  PMID:24404492
  - 435 120
Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the Maharashtra cohort of the A 1 chieve study
Uday Phadke, Sunil Gupta, Vaishali Deshmukh
November 2013, 17(8):511-515
DOI:10.4103/2230-8210.122104  PMID:24404493
  - 421 114
  Feedback 
  Subscribe